Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016
SKU ID :GD-10191669 | Published Date: 31-May-2016 | No. of pages: 275Description
TOC
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Cutaneous T-Cell Lymphoma 30
Mar 02, 2016: miRagen Therapeutics Initiates First Clinical Trial for MRG-106 in Lymphoma Patients 30
Clinical Trial Profile Snapshots 31
Appendix 272
Abbreviations 272
Definitions 272
Research Methodology 273
Secondary Research 273
About GlobalData 274
Contact Us 274
Disclaimer 274
Source 275
Tables & Figures
List of Tables
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials by Region, 2016* 6
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14
Cutaneous T-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Cutaneous T-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17
Cutaneous T-Cell Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Cutaneous T-Cell Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14
Cutaneous T-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Cutaneous T-Cell Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17
Cutaneous T-Cell Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Cutaneous T-Cell Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Cutaneous T-Cell Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 273
Companies
Celgene Corporation
Merck & Co., Inc.
Seattle Genetics, Inc.
Eisai Co., Ltd.
Takeda Pharmaceutical Company Limited
Novartis AG
BioCryst Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc.
Soligenix, Inc.
Kirin Holdings Company, Limited
- PRICE
-
$2500$7500